US 9745325
Fused heterocyclic compound
granted A61KA61K31/429A61K31/433
Quick answer
US patent 9745325 (Fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/429, A61K31/433, A61K31/4439, A61K31/444